Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
企業コードHNGE
会社名Hinge Health Inc
上場日May 22, 2025
設立日2016
最高経営責任者「CEO」Mr. Daniel (Dan) Perez
従業員数1514
証券種類Ordinary Share
決算期末May 22
本社所在地455 Market Street
都市SAN FRANCISCO
証券取引所NYSE Consolidated
国United States of America
郵便番号94105
電話番号14156898429
ウェブサイトhttps://en-gb.hingehealth.com/
企業コードHNGE
上場日May 22, 2025
設立日2016
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし